On May 24th, 2024, the Florida Spine Institute and Wellness Center, Leaders in the Treatment of Spine and Musculoskeletal Disorders, announced the publication of, Best Selling Author, Dr. Francisco M. Torres, M.D.'s new book, "Beyond Diagnosis: Perspective in Medicine and The Human Experience."

May 24, 2024 12:00 PM

"Beyond Diagnosis" contains essays previously published by KevinMD and Doximity OpMed, new introductions, and a foreword from regenerative medicine pioneer Dr. Felix Linetsky. Dr. Linetsky's foreword adds value to the book as he describes why he has maintained the same approach to patient care that he first developed in the Soviet Union, where doctors were paid the same salaries as factory workers. Dr. Torres bridges the past and future as he...

Read more

StageZero Life Sciences Announces Update on Failure to File Cease Trade Order

May 23, 2024 4:30 PM

TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, and an oncologist-led adjunctive treatment protocol with early data - METRICS study - showing an improvement in outcome in cancer patients, today...

Read more

Newport News Spine Surgeon Performs First Two-Level Cervical Disc Arthroplasty in Hampton Roads

May 23, 2024 2:45 PM

On Wednesday, Spine Surgeon Jeffrey R. Carlson, MD, performed the first two-level cervical disc arthroplasty, using the Nuvasive Simplify® cervical disc implants. The surgery was performed at Coastal Virginia Surgery Center in Newport News, Virginia and was a first for the center and this region. The two-level disc arthroplasties were performed on a 50-year-old female patient diagnosed with Foraminal Stenosis, Degenerative Disc Disease, and disc...

Read more

AGC Biologics and BioConnection Partner to Offer New End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering

May 23, 2024 11:45 AM

Strategic partnership provides a seamless one-stop-shop for biopharmaceutical development and manufacturing for large pharma, mid-size biotech's and startup developers.SEATTLE, WA and NEW YORK, NY / ACCESSWIRE / May 23, 2024 / AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and BioConnection, a specialized contract manufacturing organization (CMO) focusing on aseptic filling of vials...

Read more

Scientific Industries to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 23, 2024 11:15 AM

Investor Presentation to be held at 2:45 PM Eastern TimeBOHEMIA, NY / ACCESSWIRE / May 23, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30,...

Read more

Annual General Meeting in Cantargia AB (publ)

May 23, 2024 10:15 AM

LUND, SWEDEN / ACCESSWIRE / May 23, 2024 / Cantargia's (STO:CANTA) Annual General Meeting on 23 May 2024 resolved in accordance with the following:That no dividend would be paid.To discharge the board members and the CEO from liability with respect to their management of the company for 2023.That the board shall consist of five members with no deputies.That the remuneration to the members of the board shall amount to SEK 1,675,000 in total,...

Read more

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

May 23, 2024 9:45 AM

DALLAS, TX / ACCESSWIRE / May 23, 2024 / Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ED), hair growth, hormone replacement therapies and weight loss is excited to announce that it has engaged renown international performance marketing company, Crakmedia to champion the Company's ongoing...

Read more

Lexaria Awards Contract For Third GLP-1 Human Pilot Study

May 23, 2024 9:05 AM

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral formatKELOWNA, BC / ACCESSWIRE / May 23, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces it has hired a contract research organization ("CRO") to perform the Company's human pilot study #3, (the "Study") which will evaluate a dual action GLP-1 (glucagon-like...

Read more

Leading Massage Destination Squeeze Expands Footprint in Sarasota, Florida

May 23, 2024 9:01 AM

SARASOTA, FL / ACCESSWIRE / May 23, 2024 / Squeeze, the fast-growing massage service destination, is expanding its personalized massage footprint with the opening of its newest shop in Sarasota, Florida, this June. Conceptualized by Drybar founders, Alli Webb, Michael Landau, and previous VP of marketing Brittany Driscoll, Squeeze was created to disrupt an outdated industry by providing consumers with an accessible, stress-free, and personalized...

Read more

Aytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 23, 2024 9:00 AM

DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.WebcastThe webcasted fireside chat will...

Read more

Sinceri Senior Living Certified as a 2024 Great Place To Work

May 23, 2024 9:00 AM

VANCOUVER, WA / ACCESSWIRE / May 23, 2024 / Great Place To Work Institute and its senior care partner Activated Insights have honored Sinceri Senior Living with certification as a Great Place To Work. The 2024 Certification survey with A Great Place To Work considered over 1,800 staff surveys from across all of Sinceri's locations. The certification process involved surveying 100% of employees from across Sinceri Senior Living's locations and...

Read more

Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product

May 23, 2024 8:30 AM

Oral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task forceTop line results imminent for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea18 million people in U.S. are living with a cancer diagnosis and more than 2 million people in U.S. are expected to be diagnosed with cancer in...

Read more

Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults

May 23, 2024 8:00 AM

LAVAL, QC / ACCESSWIRE / May 23, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced additional Canadian public drug plan listings for Pr UCERIS ® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults. 1UCERIS has most recently become available for patients through the public drug plans of Alberta, Prince Edward Island and Newfoundland and Labrador, as...

Read more

OncoveryCare Partners with Tennessee Oncology and Raises $4.5M Seed Round from .406 Ventures

May 23, 2024 8:00 AM

OncoveryCare (formerly VivorCare) has closed an oversubscribed $4.5 million seed financing to launch its novel cancer survivorship care model. The fundraise was led by .406 Ventures alongside the McKay Institute for Oncology Transformation at Tennessee Oncology. Tennessee Oncology, which treats half of Tennessee's cancer patients at 35 clinical sites of care, is also a founding member of OneOncology, a fast-growth oncology platform dedicated to...

Read more

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

May 23, 2024 7:20 AM

Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1) vaccine currently in Phase 1 development; candidate jointly developed with GSKSettlement with Acuitas Therapeutics includes acknowledgment of CureVac's ownership of certain patent claims and Acuitas's licenses to selected patentsContinuation of U.S....

Read more

IRLAB Strengthens its Liquidity by Drawing SEK 25 million on a Previously Secured Loan Facility

May 23, 2024 6:50 AM

GOTHENBURG, SE / ACCESSWIRE / May 23, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 23, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, announces today that the company has made a drawdown of SEK 25 million within the framework of a loan facility totaling SEK 55 million that was issued by Fenja Capital, previously Formue Nord, in...

Read more

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.

May 23, 2024 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it has engaged Aagami, Inc. for business development, specifically to seek licensing and partnering opportunities for our assets and platform technology.The Company is currently seeking licensing and partnering opportunities for its key asset, NV-387, and its key nanoviricides™ platform technology. The...

Read more

Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy

May 23, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / May 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, recently released a white paper showcasing the effectiveness of PulseVet therapy for treating Exercise Induced Pulmonary Hemorrhage ("EIPH") in quarter horses. In addition, the paper highlights that PulseVet therapy...

Read more

Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement

May 23, 2024 4:00 AM

Nemysis is pleased to announce the further strengthening of its IP portfolio in relation to its unique and innovative nanoparticulate oral iron supplement, IHAT (Iron Hydroxide Adipate Tartrate), for the safe treatment of iron deficiency and iron deficiency anaemia.DUBLIN, IRELAND / ACCESSWIRE / May 23, 2024 / Nemysis is pleased to announce the further strengthening of its IP portfolio in relation to its unique and innovative nanoparticulate...

Read more

Spago Nanomedical Receives Declarations of Intent from the Largest Owner, Board and Management Team Regarding the Exercise of TO12

May 23, 2024 2:20 AM

LUND, SWEDEN / ACCESSWIRE / May 23, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) ("Spago Nanomedical" or the "Company") has received declarations of intent from, among others, the Company's largest owner, Peter Lindell, as well as all members of the Company's board of directors and management team, regarding the intention to exercise the warrants of series TO12 ("Warrants") for subscription of newly issued...

Read more